Brian Levy

Company: InflammX

Job title: Chief Executive Officer

Seminars:

Panel Discussion: Delving into FDA vs EU Perspective on Retinal Imaging Endpoints to Demonstrate Functional Vision 9:30 am

Detailing how the FDA and EU approach the adoption of new retinal imaging technologies Discussing the divergent regulatory standards of each organization Highlighting the growing focus on functionality and quality of life improvements for patientsRead more

day: Conference Day Two

Standardizing Data Across Retinal Imaging Modalities for Better Trial Outcomes 11:00 am

Emphasizing the importance of creating standardized protocols to ensure consistency and accuracy in multi-center trials Creating protocols to ensure harmonization of data Examining the technical barriers involved in aligning measures such as image quality, resolution, and acquisition methodsRead more

day: Conference Day Two

Fireside Chat: Commercial Trends & Opportunities in Retinal Imaging Biomarkers & Endpoints 2:00 pm

Examine the evolving landscape of retinal imaging biomarkers in AMD, focusing on advancements in detecting disease progression and treatment efficacy Analyze unmet needs and opportunities for innovation, emphasizing the potential of novel imaging technologies and AI-driven analyses to enhance precision, durability, and patient care Explore collaboration across research and industry to standardize biomarkers and accelerate…Read more

day: Conference Day Two